G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,025,000 | -94.6% | 1,000 | -99.9% | 0.06% | -96.0% |
| Q4 2018 | $19,041,000 | -43.1% | 994,287 | +55.2% | 1.55% | -29.0% |
| Q3 2018 | $33,491,000 | +7.0% | 640,481 | -11.0% | 2.18% | -6.0% |
| Q2 2018 | $31,291,000 | +17.3% | 719,985 | 0.0% | 2.32% | +16.5% |
| Q1 2018 | $26,675,000 | +49.8% | 719,985 | -19.8% | 1.99% | +6.7% |
| Q4 2017 | $17,806,000 | -20.3% | 897,505 | 0.0% | 1.86% | -52.7% |
| Q3 2017 | $22,339,000 | +166.9% | 897,505 | +87.0% | 3.94% | +184.1% |
| Q2 2017 | $8,371,000 | – | 479,986 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |